Adiponectin levels decreased with the number of 148 M PNPLA3 alleles at risk of NASH both in patients with NAFLD (p = 0.03), and in healthy subjects (p = 0.04). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.